SANDOZ PHILS CORPORATION

SANDOZ PHILS CORPORATION is primarily the local commercial and distribution arm of a global pharmaceutical manufacturer. While they may not operate large-scale manufacturing facilities for all products locally in the Philippines, they are intrinsically linked to the global manufacturing capabilities of Sandoz. Therefore, they are not a standalone "trader" of unrelated third-party goods, but rather the local entity responsible for selling and distributing products manufactured by their parent company, Sandoz, worldwide.

Company Introduction:

SANDOZ PHILS CORPORATION is the Philippine subsidiary of Sandoz, a global leader in generic pharmaceuticals and biosimilars. Sandoz is an integral part of the Novartis Group, dedicated to discovering new ways to improve and extend people's lives. In the Philippines, SANDOZ PHILS CORPORATION focuses on marketing, selling, and distributing a wide range of high-quality, affordable generic medicines, biosimilars, and over-the-counter products across various therapeutic areas. Their mission is to increase patient access to essential medicines and contribute to the country's healthcare system by providing cost-effective pharmaceutical solutions. They manage the sales, marketing, and regulatory aspects of Sandoz products within the Philippine market.

SANDOZ PHILS CORPORATION produces or sells a wide range of generic pharmaceuticals and biosimilars across various therapeutic areas. Their product portfolio typically includes:

Cardiovascular products

Central Nervous System products

Oncology products

Respiratory products

Gastroenterology products

Anti-infectives

Pain and Inflammation products

Dermatology products

Biosimilars

Endocrine and Metabolic products